S. Deb

perspective on the role of targeted therapies in gastroesophageal cancer

S. Fox, N. Tebbutt, D. Ferraro, 2011 .

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas

S. Fox, J. Tuynman, R. Ward, 2014, British Journal of Cancer.

COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment

S. Fox, A. Harris, D. Generali, 2014, British Journal of Cancer.

Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations

S. Fox, H. Do, A. Dobrovic, 2014, British Journal of Cancer.

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Jane E. Carpenter, Jack A. Taylor, S. Cross, 2022, Breast Cancer Research.